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Abstract 25 
Unilateral Raynaud’s phenomenon is a rare clinical condition caused predominantly by a 26 
thoracic outlet syndrome and characterized by significant morbidity that can lead to digital 27 
ulceration associated sometimes with deep tissue necrosis, gangrene and amputation. Recent 28 
studies showed the beneficial effect of PDE-V-inhibitor sildenafil in Raynaud’s phenomenon 29 
and limb ischemia of improved microcirculation. We report for the first time, a case where 30 
oral sildenafil permitted amputation avoidance in a woman presenting severe acute digital 31 
ischemia caused by a ‘cervical rib’. Therefore, therapy of ischemia with sildenafil could be an 32 
effective treatment option in patients not responding to classical drugs. 33 
 34 
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Introduction 37 
Unilateral Raynaud’s phenomenon is a rare clinical condition caused most of the time by a 38 
thoracic outlet syndrome. Vascular complications of this syndrome arise as a result of the 39 
intermittent but long-term compression of the subclavian artery by cervical rib, cartilage or 40 
fibrous band. They can lead to digital ulceration, necrosis and even amputation for the worst 41 
cases (1, 2). 42 
We report a case of unilateral Raynaud’s phenomenon secondary to cervical rib in which 43 
distal thromboembolism occurred. Due to the major vascular limitation, it was proposed to 44 
amputate the mid-forearm. Parallel, the patient saw a German television show where Viagra® 45 
was used for ulcerations of the digits in cases of scleroderma, and asked her doctors if this 46 
might be an option. 47 
 48 
Case Description 49 
We present the case of a 37-year-old woman who developed critical upper limb ischemia for 50 
whom we introduced sildenafil (Viagra®, Pfizer AG), a PDE-V-inhibitor, to avoid amputation 51 
of the lower forearm. In August 2001, she was admitted to the Emergency Unit (University 52 
Hospital of Lausanne) complaining of increasing pain in the right forearm and frigid hand 53 
extremity. Her past medical history included a non-treated Raynaud’s phenomenon of the 54 
right hand diagnosed 5 months before with multiple associated risk factors including heavy 55 
smoking (46 pack-year), oral contraception (over 20 years), manual labor as a waitress and 56 
the cold climate of Switzerland. 57 
Initially, the angiography showed occlusions of the radial and ulnar arteries at the level of the 58 
distal third of the right forearm (Figure 1A). The patient was therefore diagnosed with stage 59 
IV acute ischemia with no specific etiology. Therapeutic heparin anticoagulation 60 
(Liquemine®, Drossapharm AG; 20,000 U/24h) was introduced as well as i.v. nitroglycerine, 61 
and sub-cutaneous morphine for pain management. Since there was no improvement of 62 
symptoms, thrombolytic therapy with urokinase (Pharma Consulting AG; 40,000 U/h) was 63 
introduced but failed. The clinical situation deteriorated with the appearance of small necrotic 64 
lesions on the thumb and index finger of the right hand. Therefore, a treatment with Iloprost 65 
(Ilomedin®, Bayer AG; 0.5 slowly increased to 2 µg/kg/min) was begun but tissue necrosis 66 
kept advancing. The decision was taken to perform a bypass between the brachial and the 67 
interosseous arteries with interposition of a reversed great saphenous vein graft. Initially, 68 
clinical features improved but a few days later, an extensive thrombosis of the whole arterial 69 
network, including the bypass and the brachial artery developed. Given the dramatic 70 
evolution, a neuro-stimulator was implanted with the aim to diminish pain and allow 71 
vasodilatation of upper-limb capillary network. Slight clinical improvement evolved and the 72 
patient could leave the hospital but with full therapeutic anticoagulation with acenocoumarol 73 
(Sintrom®, Novartis AG) and heavy dose morphine. Despite the remaining critical ischemia, 74 
the situation remained stable during a few months. However, during winter, clinical 75 
deterioration occurred with extensive necrosis of the distal phalanx of the right thumb and 76 
index finger, which were complicated with local infection.  77 
Consequently, amputation of partial distal phalanx of right thumb and index was performed. 78 
Recovery was not easy since the amputation stumps had become necrotic, leaving the bony 79 
part of the proximal phalanx of the thumb and the intermediate phalanx of the index finger 80 
exposed. An amputation above the elbow was considered, a site where trans-cutaneous 81 
oxygen pressure was still compatible with wound healing. At this time, the patient asked to be 82 
treated with sildenafil after having seen a German television program about reimbursement 83 
polemic on Viagra® and his use as treatment in patients suffering scleroderma. Sadly, this 84 
treatment alternative was not considered as serious by most health professionals. A multi-85 
disciplinary council took place, where angiologists and plastic surgeons stated for this option 86 
against others. The decision was then made to treat the patient with low dose Viagra® (25 mg, 87 
three times a day for six weeks) under strict medical supervision.  88 
Vascular evaluation pre- and post-sildenafil treatment was conducted. The plethysmographic 89 
pressures of the right hand were well below normal values (Table 1), as well as trans-90 
cutaneous oxygen pressure (data not shown). Sildenafil was introduced gradually and was 91 
well tolerated without any undesirable effects. Clinical situation improved rapidly with a clear 92 
decrease in pain and heavy analgesic medication could also be completely withdrawn. One 93 
week after introducing sildenafil, granulation tissue appeared in the extremities and bleeding 94 
occurred when bandages were changed. One month later, the right thumb and index were 95 
nearly completely covered with granulation tissue (Figure 2A). Two months later, a Doppler 96 
ultrasound examination showed arterial collateral development between humeral and 97 
interosseous arteries at the proximal third of the forearm. The radial artery was only distally 98 
perfused collaterally from the interosseous artery and the ulnar artery was also perfused with a 99 
very weak flow (data not shown).  100 
Because of the promising evolution, the decision was made to continue treatment for several 101 
months to allow collateral vascularization to develop and provide maximal cover before the 102 
cold winter months. Eventually, sildenafil treatment was reduced and stopped (total of 6 103 
months) and no complications were observed during or after treatment. Functional limitation 104 
of the metacarpophalangeal and interphalangeal joints continued until the end of the treatment 105 
and severe bone-muscle atrophy was also the consequence of the ischemia. Even though oral 106 
anticoagulant therapy with acenocoumarol (INR target of 2-3) was continued, another episode 107 
of arterial thrombosis occurred. Vascular imaging follow-up showed thrombosis of the right 108 
subclavian artery and truncus brachiocephalicus. CT scan portrayed a right cervical rib 109 
articulating with the first rib and compressing the subclavian artery (Figure 1B&C).  110 
 111 
Unfortunately, this diagnosis was initially not given and the cervical rib was only found after 112 
a second thrombotic event 2 years following the first episode. Retrospectively, there was 113 
some evidence before that time that compression of the right subclavian artery was suspected 114 
upon Doppler ultrasound and the same malformation was noted after a vascular examination.  115 
Fortunately for our patient with relation to the chronic situation, she had already developed 116 
collateral arteries that provided a detour so the thrombosis had limited clinical effect. Overall, 117 
the cervical rib could explain both the unilateral Raynaud’s phenomenon, diagnosed a few 118 
months earlier, as well as the unsuccessful outcome of the vascular by-pass performed after 119 
the first vascular occlusion. The effect of anticoagulation medication in this case was 120 
negligible and despite its administration from the very beginning, the clinical situation 121 
continued to decline. Furthermore, the anticoagulation was stopped later considering the 122 
thrombosis was a consequence of a mechanical problem. Still today, our patient has not been 123 
operated for the problem of cervical rib, since she has been without vascular symptoms for 124 
more than 12 years. 125 
 126 
Discussion 127 
Sildenafil seems to have important effects in peripheral ischemia, particularly for the upper 128 
limb. Until now, Sildenafil has mainly been used for erectile dysfunction and pulmonary 129 
hypertension (3, 4). Recently, there have been promising reports of other uses for sildenafil, 130 
such as peripheral ischemia as well as primary and secondary Raynaud’s phenomenon, but 131 
findings are still in preliminary stages (5, 6). 132 
Sildenafil activates the nitric oxide (NO)/protein kinase G (PKG) pathway, which has an 133 
important role in vascular tone regulation and an important role in neovascularization 134 
especially favouring arteriogenesis. Moreover, it is regarded as a powerful vasodilator in 135 
ischemia (5, 7). 136 
In addition, different studies have shown a beneficial effect of sildenafil in the treatment of 137 
peripheral vascular problems. Roland Fries et al. (2005) showed that sildenafil significantly 138 
increased microcirculation and diminished symptoms in patients with Raynaud’s phenomenon 139 
resistant to classical vasodilator treatments. The study showed that after administration of 50 140 
mg of sildenafil for 4 weeks, the flow velocity increased by more than 400% (8). 141 
Different cases of treatment with sildenafil in patients with digital ulcers due to scleroderma 142 
are reported, as in the article by Friedrichson et al. (2008), which showed that after 5 weeks of 143 
treatment with 75 mg of Sildenafil, digital ulcers disappeared (9). 144 
In the present paper, we report the first case where sildenafil has led to a rapid improvement 145 
of symptoms of acute ischemia, including pain, wound healing and amputation avoidance, 146 
caused by a malformation of the subclavian artery. The improvements began already from the 147 
7th day of treatment with sildenafil which was the time needed for the development of 148 
effective angiogenesis revascularization of the ischemic limb as shown in experimental works 149 
(5). 150 
Unfortunately, description of treatment of ischemic limb by sildenafil is lacking. 151 
Retrospectively, we believe that treatment could probably have been stopped sooner because 152 
of improvement related to the development of an effective angiogenesis and as soon as the 153 
value of tissue oxygen pressure was stabilized. The long-term monitoring confirms our 154 
hypothesis, since 12-year follow-up for the vascular parameters remain stable and identical to 155 
that found at the discontinuation of the sildenafil treatment. 156 
The upper limb of this patient was saved but due to late introduction of sildenafil and 157 
therefore prolonged ischemia, a functional limitation of the metacarpophalangeal and 158 
interphalangeal joints persists and has not improved for the last 12 years. The patient is unable 159 
to work and therefore has ever since been on welfare and following professional reinsertion 160 
programs without success. 161 
 162 
Conclusion 163 
In conclusion, acute ischemia of the superior limb is a rare and dramatic complication of a 164 
cervical rib. Our clinical case would show that through its effect on angiogenesis, sildenafil 165 
was responsible for saving the limb of our patient from amputation and also responsible to 166 
avoid surgical intervention for resection of the cervical rib. Importantly, no side effects of 167 
sildenafil were detected. This case shows the important role of sildenafil in the treatment of 168 
ischemic extremities that often happens in vascular diseases, diabetes, and arthritis. Due to 169 
sildenafil’s value in possible amputation avoidance, further work is merited to clarify 170 
mechanisms and modalities of treatment. With television emissions specializing in medical 171 
topics, the public can actively participate in their treatment regimens. This scenario happened 172 
recently when a patient with a degrading metal hip prosthesis had cobalt poisoning and saw a 173 
similar situation in the TV series with Dr. House (10). Importantly, the open discussion with 174 
patients can sometimes be profitable. 175 
 176 
 177 
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Table 1: Patient Vascular Data.  222 
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Figure 1.  232 
Radiologic studies A. Angiographic study of the vasculature of the right forearm, executed in 233 
August 2001 when the patient was first admitted to the hospital. Radial artery is occluded at 234 
the distal third (white arrow). The proximal two third of the ulnar artery is occluded (black 235 
arrow) and only little vascularized by small collateral arteries from the interosseous artery 236 
permitting a slight a reprise of the ulnar artery at the carpal portion third (black triangle). B. 237 
2D reconstruction of a CT-scan done in 2003 showing a thrombosis of the subclavian artery 238 
(black arrows). C. 3D reconstruction from the same CT scan showing the right cervical rib 239 
(white arrows) in with relation to the vasculature.  240 
 241 
 242 
Figure 2. 243 
Topical aspect of the hand. A. One month after introducing sildenafil, the right thumb and 244 
index were nearly completely covered with granulation tissue. B. Twelve years later. 245 
 246 
